Login / Signup

Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.

David R FreyerLi LinJennifer W MackScott H MaurerMolly McFatrichJustin N BakerShana S JacobsNicole LucasJanice S WithycombeDeborah TomlinsonKatie Rose VillabrozaMia K WaldronPamela S HindsBryce B Reeve
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Compared with children, symptomatic AEs were consistently under-reported by clinicians with low agreement and over-reported by caregivers with low-moderate agreement. Direct reporting by children using Ped-PRO-CTCAE or similar measures should be routinely incorporated for toxicity assessment in clinical trials.
Keyphrases
  • clinical trial
  • palliative care
  • young adults
  • adverse drug
  • randomized controlled trial
  • emergency department
  • open label
  • phase ii
  • study protocol